| 5-fluoro-2-(6-fluoro-2-methyl-1H-benzimidazol-1-yl)-N-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine |
PTC596 |
1610964-64-1 |
| Ethyl 4-(2-(4,6-dimethyl-3-oxoisothiazolo[5,4-b]pyridin-2(3H)-yl)acetyl)piperazine-1-carboxylate |
Ethyl 4-(2-(4,6-dimethyl-3-oxoisothiazolo[5,4-b]pyridin-2(3H)-yl)acetyl)piperazine-1-carboxylate |
902589-96-2 |
| CRANAD 28 |
CRANAD 28 |
1623747-97-6 |
| PCNA-I1 |
PCNA-I1 |
444930-42-1 |
| OSMI-1 |
OSMI-1 |
1681056-61-0 |
| ML-299 |
ML-299 |
1426916-00-8 |
| GNE-495 |
GNE-495 |
1449277-10-4 |
| N-((2R,3S)-2-(4-Chlorophenyl)-1-(1,4-dimethyl-2-oxo-1,2-dihydroquinolin-7-yl)-6-oxopiperidin-3 |
化合物LP99 |
1808951-93-0 |
| ML-191 |
ML-191 |
931695-79-3 |
| ML-179 |
ML-179 |
1883548-87-5 |
| THAL-SNS-032 |
THAL-SNS-032 |
2139287-33-3 |
| EGFR-IN-7 (compound 34) |
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 |
2267329-76-8 |
| WWL229 |
WWL229 |
1338575-28-2 |
| ML335 |
ML335 |
1069498-96-9 |
| glucagon receptor antagonists-4 |
GLUCAGON RECEPTOR ANTAGONISTS-4 |
1393124-08-7 |
| (S)-1-((5-chloropyridin-3-yl)methyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one |
CS-2552 |
1523406-39-4 |
| WIKI4 |
化合物WIKI4 |
838818-26-1 |
| GSK484 |
CS-2265 |
1652591-81-5 |
| MS023 |
N1-甲基-N1-[[4-[4-(异丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺 |
1831110-54-3 |
| Debio-1347 |
DEBIO-1347 |
1265229-25-1 |
QQ
微信
